Projects

Mgr. Iveta Štibrániová, PhD.
senior scientist

International

Current
  • Alliance4Life Bridging the Research and Innovation Gap in Life Sciences
    Program: Horizon Europe
    Duration: 1. 3. 2024 – 29. 2. 2028
Finished
  • A4L_BRIDGE Expression of immune genes in human skin non-immune cells affected by TBEV infection
    Program: Other
    Duration: 1. 11. 2024 – 31. 10. 2025
  • CAPSID - Scientific capacity building in biomedical research through scientific exchange and co-development of research services
    Program: European Regional Development Fund (ERDF)
    Duration: 1. 7. 2018 – 30. 6. 2021

National

Current
  • Innate antiviral defense responses of selected human skin cells to tick-borne encephalitis virus and their modulation by bioactive substances in tick saliva
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Using an electron microscope to observe the skin cells\' mutual interaction and ultrastructural changes after TBEV infection
    Program: DoktoGrant
    Duration: 1. 1. 2024 – 31. 12. 2024
  • Isolation, identification and characterization of transforming growth factor-beta 1 binding molecule(s) in tick salivary gland extracts.
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Monitoring of tick saliva immunomodulators effects on innate antiviral responses of skin
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Imunomodulatory properties of the murine herpesvirus M3 protein and the role of ticks in herpesvirus circulation in nature
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Effect of salivary gland extracts derived from different tick species on induction and biological activity of interferon-lambda 1.
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Biological significance and pharmacological features of bioactive proteins in tick saliva
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Murine gammaherpesvirus a producent of substances exhibiting immunomodulatory and antiproliferative properties
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Bioactive molecules in tick saliva and their exploitation in the regulation of cell processes in physiological and physiological conditions
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Immunological and immunomodulatory abilities of murine herpes virus with regard to the production of the growth factors
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Murine herpesvirus, a model to study human oncogenic herpesviruses: viral imunomodulator M3 protein and factors important for virus spread among hosts
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Development of biopharmaceutics by modern biotechnology
    Program: EU Structural Funds Research & Development
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Identification of selected bioactive molecules secreted in tick saliva
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Structural and functional analysis of new candidates of anti-tick vaccines
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Identification, expression and use of bioactive substances from parasitic helmints, ticks and insects in clinical medicine
    Program:
    Duration: 1. 1. 2009 – 30. 10. 2010
  • Molecular-biological characterization of selected tick’s salivary proteins as a potential antigens for development of anti-tick vaccines
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Effects of tick saliva immunosupressant on host immune system and pathogen transmission
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
Employees